Summary of Study
Lewy Body Dementia (LBD) can affect all areas of a person’s life. However, currently, it is difficult to identify and treat. By gathering clinical information from LBD patients, we hope to create a robust resource for future researchers to find better ways to identify and treat the disease. (Location: VA Puget Sound Health Care System).
The purpose of the Dementia with Lewy Bodies Consortium is to develop a collection of samples from individuals diagnosed with dementia with Lewy bodies (DLB), dementia with Lewy bodies/MCI, or Parkinson's disease dementia who will be followed over time. The consortium will collect detailed clinical information, biospecimens, and imaging data. Led by top leaders in the field, this consortium will fill the gap in resources available for biomarker development in Lewy Body Dementia and promote additional future research by having a readily available subject sample.
Eligibility Criteria
Patients may qualify for this study if they meet the requirements:
- Have a probable diagnosis of:
- Dementia with Lewy bodies
- Dementia with Lewy bodies/mild cognitive impairment (MCI)
- Parkinson's disease dementia
- Parkinson's disease dementia/mild cognitive impairment (MCI)
- Have a study partner who is able and willing to comply with required study procedures
- Have at least eight years of education
The study doctor will also check for other medical conditions or reasons that might prevent you from participating in the study.
More Information
If interested, please contact the study coordinator: Kevin Vintch (Kevin.Vintch@va.gov) 206-277-1024